About Kimberly-Clark Corporation
https://www.kimberly-clark.comKimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional.
CEO
Michael D. Hsu
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2014-11-03 | Forward | 1043:1000 |
| 1997-04-03 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 784
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Argus Research
Buy
RBC Capital
Outperform
Piper Sandler
Overweight
Wells Fargo
Equal Weight
Morgan Stanley
Equal Weight
Barclays
Equal Weight
Grade Summary
Showing Top 6 of 12
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:40.53M
Value:$4.02B
BLACKROCK INC.
Shares:31.39M
Value:$3.11B
BLACKROCK, INC.
Shares:28.11M
Value:$2.79B
Summary
Showing Top 3 of 2,398
About Kimberly-Clark Corporation
https://www.kimberly-clark.comKimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $4.13B ▼ | $855M ▼ | $446M ▼ | 10.79% ▼ | $1.34 ▼ | $833M ▲ |
| Q2-2025 | $4.16B ▼ | $864M ▼ | $509M ▼ | 12.23% ▲ | $1.53 ▼ | $802M ▼ |
| Q1-2025 | $4.84B ▼ | $964M ▼ | $567M ▲ | 11.71% ▲ | $1.71 ▲ | $976M ▲ |
| Q4-2024 | $4.93B ▼ | $1.13B ▲ | $447M ▼ | 9.07% ▼ | $1.34 ▼ | $760M ▼ |
| Q3-2024 | $4.95B | $630M | $907M | 18.32% | $2.7 | $1.35B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $617M ▼ | $16.89B ▲ | $15.56B ▲ | $1.33B ▲ |
| Q2-2025 | $634M ▲ | $16.77B ▲ | $15.37B ▲ | $1.27B ▲ |
| Q1-2025 | $563M ▼ | $16.3B ▼ | $15.08B ▼ | $1.1B ▲ |
| Q4-2024 | $1.02B ▼ | $16.55B ▼ | $15.57B ▼ | $840M ▼ |
| Q3-2024 | $1.11B | $17.16B | $15.72B | $1.28B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $454M ▼ | $708M ▼ | $312M ▲ | $1.18B ▲ | $-40M ▼ | $1.11B ▲ |
| Q2-2025 | $512M ▼ | $770M ▲ | $-193M ▼ | $-500M ▲ | $94M ▲ | $573M ▲ |
| Q1-2025 | $573M ▲ | $327M ▼ | $-119M ▲ | $-683M ▲ | $-458M ▼ | $123M ▼ |
| Q4-2024 | $452M ▼ | $817M ▼ | $-194M ▼ | $-686M ▲ | $-90M ▼ | $608M ▼ |
| Q3-2024 | $935M | $958M | $470M | $-1.48B | $-52M | $798M |
Revenue by Products
| Product | Q2-2024 | Q3-2024 | Q1-2024 | Q4-2024 |
|---|---|---|---|---|
 Consumer Tissue | $1.50Bn ▲ | $1.54Bn ▲ | $1.60Bn ▲ | $1.52Bn ▼ |
 KC Professional | $800.00M ▲ | $770.00M ▼ | $820.00M ▲ | $0 ▼ |
 Personal Care | $0 ▲ | $0 ▲ | $2.71Bn ▲ | $0 ▼ |
CEO
Michael D. Hsu
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2014-11-03 | Forward | 1043:1000 |
| 1997-04-03 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 784
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Argus Research
Buy
RBC Capital
Outperform
Piper Sandler
Overweight
Wells Fargo
Equal Weight
Morgan Stanley
Equal Weight
Barclays
Equal Weight
Grade Summary
Showing Top 6 of 12
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:40.53M
Value:$4.02B
BLACKROCK INC.
Shares:31.39M
Value:$3.11B
BLACKROCK, INC.
Shares:28.11M
Value:$2.79B
Summary
Showing Top 3 of 2,398